Takeda Pharmaceutical Company Limited Stock Deutsche Boerse AG
Stocks
TKDA
US8740602052
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
After hours 16:00:02 | |||
| 14.70 EUR | +2.08% |
|
14.45 | -1.70% |
| Market Cap | 8,402B 51.76B 45.4B 42.05B 38.69B 73.18B 4,954B 74.6B 501B 197B 2,433B 194B 190B | P/E 2027 * |
43.2x | P/E 2028 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 12,287B 75.7B 66.39B 61.49B 56.58B 107B 7,245B 109B 733B 287B 3,558B 284B 278B | EV / Sales 2027 * |
2.65x | EV / Sales 2028 * | 2.59x |
| Free-Float |
99.26% | Yield 2027 * |
3.84% | Yield 2028 * | 3.92% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +0.35% | ||
| 1 week | -0.68% | ||
| Current month | +5.76% | ||
| 1 month | +8.09% | ||
| 3 months | -3.92% | ||
| 6 months | +6.52% | ||
| Current year | +11.36% |
| 1 week | 14.4 |  | 14.7 |
| 1 month | 13.3 | | 14.8 |
| Current year | 12.8 | | 16.1 |
| 1 year | 11.3 | | 16.1 |
| 3 years | 11.3 | | 16.1 |
| 5 years | 11.3 | | 16.1 |
| 10 years | 11.3 | | 19.27 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2026-06-23 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 2024-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 2022-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 2015-05-31 |
Steven Gillis
BRD | Director/Board Member | 73 | 2018-12-31 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 2024-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.08% | -0.68% | - | - | 52.42B | |
| -0.56% | -1.52% | +47.86% | +171.88% | 1,060B | |
| +0.31% | -0.60% | +64.37% | +62.31% | 619B | |
| -0.03% | -2.65% | +29.49% | +85.64% | 438B | |
| -1.75% | -0.33% | +28.33% | +23.58% | 333B | |
| +0.24% | -0.42% | +29.19% | +47.26% | 282B | |
| -1.75% | -10.57% | +18.27% | +22.07% | 267B | |
| +0.67% | +1.03% | -26.81% | -37.96% | 218B | |
| -0.81% | -1.63% | +21.35% | +58.33% | 196B | |
| +1.21% | +1.38% | +17.23% | +71.29% | 161B | |
| Average | -0.38% | -3.33% | +25.47% | +56.05% | 397.1B | |
| Weighted average by Cap. | -0.43% | -3.10% | +35.57% | +83.94% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,630B 28.53B 25.02B 23.17B 21.32B 40.33B 2,730B 41.11B 276B 108B 1,341B 107B 105B | 4,701B 28.96B 25.4B 23.53B 21.65B 40.94B 2,772B 41.74B 280B 110B 1,361B 109B 106B |
| Net income | 184B 1.13B 994M 920M 847M 1.6B 108B 1.63B 10.97B 4.3B 53.25B 4.25B 4.16B | 309B 1.91B 1.67B 1.55B 1.42B 2.69B 182B 2.75B 18.45B 7.24B 89.56B 7.16B 7B |
| Net Debt | 3,886B 23.94B 21B 19.45B 17.89B 33.84B 2,291B 34.5B 232B 90.9B 1,125B 89.89B 87.92B | 3,750B 23.1B 20.27B 18.77B 17.27B 32.67B 2,211B 33.3B 224B 87.74B 1,086B 86.76B 84.86B |
| Date | Price | Change |
|---|---|---|
| 26-07-13 | €14.70 | +2.08% |
| 26-07-10 | €14.40 | -0.69% |
| 26-07-09 | €14.50 | -1.36% |
| 26-07-08 | €14.70 | +0.68% |
| 26-07-07 | €14.60 | -1.35% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
- TKDA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
